Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04494958
Title Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer (PALBOBIN)
Acronym PALBOBIN
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Fundacion Oncosur
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.